QIAGEN generated about $2.09 billion of 2025 revenue, $466 million of operating income and $654 million of operating cash flow. The thesis depends on sample-to-insight diagnostics demand, consumables quality, regional exposure, capital discipline and debt-funded portfolio investment.
The valuation workbench is hidden from non-admin users until market-data licensing and trust disclosures are production-ready.
